Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Garden

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 4, 2006
New thoughts on the pathobiology of regimen-related mucosal injuryLowell Anthony, Joanne Bowen, Adam Garden, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 26, 2015
Reply to D. Adkins et alRita S Axelrod, Eric Sherman, Adam Garden, et al.
Cancer|October 25, 2011
Prognosis and risk factors for early-stage adenoid cystic carcinoma of the major salivary glandsMihir K Bhayani, Murat Yener, Adel El-Naggar, et al.
Journal of Applied Clinical Medical Physics|April 30, 2022
Knowledge-based planning for the radiation therapy treatment plan quality assurance for patients with head and neck cancerWenhua Cao, Mary Gronberg, Adenike Olanrewaju, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2006
Disadvantage of men living alone participating in Radiation Therapy Oncology Group head and neck trialsAndre A Konski, Thomas F Pajak, Benjamin Movsas, et al.
Practical Radiation Oncology|July 29, 2017
Postoperative local-regional radiation therapy in the treatment of parathyroid carcinoma: The MD Anderson experience of 35 yearsIoannis Christakis, Angelica M Silva, Michelle D Williams, et al.
Cancer|February 26, 2004
A Phase II study of docetaxel and carboplatin as neoadjuvant therapy for nasopharyngeal carcinoma with early T status and advanced N statusFaye M Johnson, Adam Garden, J Lynn Palmer, et al.
Cancer|July 19, 2002
Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neckDong M Shin, Bonnie S Glisson, Fadlo R Khuri, et al.
Clinical and Translational Radiation Oncology|August 25, 2021
Factors associated with complex oral treatment device usage in patients with head and neck cancerStephen Palasi, Ning Zhang, Mikaela Bankston, et al.
International Journal of Radiation Oncology, Biology, Physics|February 18, 2004
A multinational, randomized phase III trial of iseganan HCl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancyAndy Trotti, Adam Garden, Padraig Warde, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 4, 2006
New thoughts on the pathobiology of regimen-related mucosal injuryLowell Anthony, Joanne Bowen, Adam Garden, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 26, 2015
Reply to D. Adkins et alRita S Axelrod, Eric Sherman, Adam Garden, et al.
Cancer|October 25, 2011
Prognosis and risk factors for early-stage adenoid cystic carcinoma of the major salivary glandsMihir K Bhayani, Murat Yener, Adel El-Naggar, et al.
Journal of Applied Clinical Medical Physics|April 30, 2022
Knowledge-based planning for the radiation therapy treatment plan quality assurance for patients with head and neck cancerWenhua Cao, Mary Gronberg, Adenike Olanrewaju, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2006
Disadvantage of men living alone participating in Radiation Therapy Oncology Group head and neck trialsAndre A Konski, Thomas F Pajak, Benjamin Movsas, et al.
Practical Radiation Oncology|July 29, 2017
Postoperative local-regional radiation therapy in the treatment of parathyroid carcinoma: The MD Anderson experience of 35 yearsIoannis Christakis, Angelica M Silva, Michelle D Williams, et al.
Cancer|February 26, 2004
A Phase II study of docetaxel and carboplatin as neoadjuvant therapy for nasopharyngeal carcinoma with early T status and advanced N statusFaye M Johnson, Adam Garden, J Lynn Palmer, et al.
Cancer|July 19, 2002
Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neckDong M Shin, Bonnie S Glisson, Fadlo R Khuri, et al.
Clinical and Translational Radiation Oncology|August 25, 2021
Factors associated with complex oral treatment device usage in patients with head and neck cancerStephen Palasi, Ning Zhang, Mikaela Bankston, et al.
International Journal of Radiation Oncology, Biology, Physics|February 18, 2004
A multinational, randomized phase III trial of iseganan HCl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancyAndy Trotti, Adam Garden, Padraig Warde, et al.
Pageof 2